About MC Diagnostics
MC Diagnostics is a company based in Llandudno (United Kingdom) founded in 2006 by Peter Maguire was acquired by ACT Genomics in July 2021. The company has 16 employees as of January 31, 2021. MC Diagnostics offers products and services including HLA Antibody Detection, NGS HLA Typing, Custom Microarray Printing, and Blood Group Serology. MC Diagnostics operates in a competitive market with competitors including Aethon, Hamilton Company, Stratec Biomedical, MEGAROBO and LabMinds, among others.
- Headquarter Llandudno, United Kingdom
- Employees 16 as on 31 Jan, 2021
- Founders Peter Maguire
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Mc Diagnostics Ltd
- Date of Incorporation 12 Jun, 2006
- Jurisdiction WIRRAL, UNITED KINGDOM
-
Annual Revenue
$1.11 M (USD)0as on Dec 31, 2021
-
Net Profit
$117.86 K (USD)-32as on Dec 31, 2023
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
16
as on Jan 31, 2021
-
Acquired by
ACT Genomics
(Jul 06, 2021)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of MC Diagnostics
MC Diagnostics offers a comprehensive portfolio of products and services, including HLA Antibody Detection, NGS HLA Typing, Custom Microarray Printing, and Blood Group Serology.
Detects antibodies for organ transplant compatibility
Provides next-generation sequencing for HLA analysis
Designs and prints DNA probes for diagnostic assays
Performs serological typing for blood compatibility
Funding Insights of MC Diagnostics
Detailed funding history for MC Diagnostics
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in MC Diagnostics
MC Diagnostics has secured backing from 1 investor. Prominent investors backing the company include ACT Genomics.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Genomics services for cancer clinical and research needs are delivered.
|
Locked | Locked | Locked |
Investor details for MC Diagnostics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by MC Diagnostics
Investment portfolio details for MC Diagnostics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - MC Diagnostics
Detailed financials for MC Diagnostics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Mc Diagnostics Comparisons
Peer comparison for MC Diagnostics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of MC Diagnostics
MC Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Aethon, Hamilton Company, Stratec Biomedical, MEGAROBO and LabMinds, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Autonomous robots are deployed for hospital internal logistics and deliveries.
|
|
| Locked | Locked | Locked |
Developer of automated liquid handling systems
|
|
| Locked | Locked | Locked |
Provider of automated analyzer systems, data management software, and solutions for IVD sample preparation
|
|
| Locked | Locked | Locked |
Robotic solutions for industrial laboratory automation are provided by MEGAROBO.
|
|
| Locked | Locked | Locked |
Automated liquid handling systems are manufactured for lab solution preparation.
|
|
| Locked | Locked | Locked |
Robotic platforms for lab automation are developed.
|
Detailed competitors of MC Diagnostics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Mc Diagnostics
Complete news archive for MC Diagnostics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about MC Diagnostics
MC Diagnostics was founded in 2006.
MC Diagnostics is headquartered in Llandudno, United Kingdom. It is registered at Llandudno, Wales, United Kingdom.
Peter Maguire is the current CEO of MC Diagnostics. They have also founded this company.
As of Jan 31, 2021, the latest employee count at MC Diagnostics is 16.
Annual revenue of MC Diagnostics is $1.11M as on Dec 31, 2021.
MC Diagnostics was established in 2006 in Llandudno, United Kingdom, within the molecular diagnostics sector. Expertise is focused on automating multiplexed molecular assays. Robotic automated processors and custom image analysis software are included in the product offerings. Custom assay development services are also provided to support diagnostic operations.
MC Diagnostics's top competitors include Aethon, MEGAROBO and Hamilton Company.
MC Diagnostics offers HLA Antibody Detection, NGS HLA Typing, Custom Microarray Printing, and Blood Group Serology.
MC Diagnostics has 1 investor. Key investors include ACT Genomics.